Lyra Therapeutics Inc. (LYRA)

0.20

-0.01 (-6.54%)

At close: Mar 03, 2025, 3:59 PM

0.20

2.41%

After-hours: Mar 03, 2025, 04:58 PM EST

Lyra Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-62.68M	-55.28M	-43.51M	-22.13M	-16.31M	-6.03M
Depreciation & Amortization	278K	1.07M	1M	95K	27K	82K
Stock-Based Compensation	5.89M	5.45M	2.77M	1.81M	244K	406K
Other Working Capital	-5.33M	6.97M	11.57M	-1.22M	2.32M	-55K
Other Non-Cash Items	-1.9M	824K	2.42M	-45K	167K	-1.18M
Deferred Income Tax	n/a	n/a	-2.42M	n/a	n/a	n/a
Change in Working Capital	-4.88M	4.55M	13.92M	-879K	2.11M	79K
Operating Cash Flow	-63.3M	-43.38M	-25.82M	-21.14M	-13.75M	-6.64M
Capital Expenditures	-1.05M	-164K	-3.38M	-1.77M	-211K	-37K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-122.42M	-64.84M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	110.89M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-1	-64.84M	n/a	n/a	n/a	n/a
Investing Cash Flow	-12.58M	-65.01M	-3.38M	-1.77M	-211K	-37K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	500K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.55M	-4.24M	359K	27.81M	-115K	57.71M
Financial Cash Flow	65.69M	96.26M	359K	87.7M	-115K	29.21M
Net Cash Flow	-10.2M	-12.13M	-28.85M	64.78M	-14.08M	22.54M
Free Cash Flow	-64.35M	-43.55M	-29.2M	-22.92M	-13.96M	-6.68M